Literature DB >> 9217699

Diagnosis of visceral leishmaniasis by the polymerase chain reaction using blood, bone marrow and lymph node samples from patients from the Sudan.

K Andresen1, S Gasim, A M Elhassan, E A Khalil, D C Barker, T G Theander, A Kharazmi.   

Abstract

We have evaluated the sensitivity of the polymerase chain reaction (PCR) as a diagnostic tool for Leishmania donovani using blood, bone marrow and lymph node samples from Sudanese patients with a confirmed infection. Forty patients were diagnosed by microscopic examination of bone marrow or lymph node samples. The PCR was able to detect parasite DNA in 37 out of 40 blood samples. In bone marrow and lymph node samples, the PCR was able to detect parasite DNA in all 7 and 6 samples, respectively. We suggest that the PCR should be considered as a valuable and sensitive tool for the diagnosis of L. donovani infection. However, if PCR diagnosis is to supplement or even replace microscopic diagnosis in developing countries, a large number of patients with no apparent signs of infection and patients with other diseases have to be tested in order to evaluate its true potential.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9217699

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  9 in total

Review 1.  Laboratory diagnosis of visceral leishmaniasis.

Authors:  Shyam Sundar; M Rai
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

Review 2.  Diagnosis of visceral leishmaniasis: developments over the last decade.

Authors:  Gurumurthy Srividya; Arpita Kulshrestha; Ruchi Singh; Poonam Salotra
Journal:  Parasitol Res       Date:  2011-11-09       Impact factor: 2.289

3.  Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis.

Authors:  P Salotra; G Sreenivas; G P Pogue; N Lee; H L Nakhasi; V Ramesh; N S Negi
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

4.  Optimized PCR using patient blood samples for diagnosis and follow-up of visceral Leishmaniasis, with special reference to AIDS patients.

Authors:  L Lachaud; J Dereure; E Chabbert; J Reynes; J M Mauboussin; E Oziol; J P Dedet; P Bastien
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

5.  Peripheral blood buffy coat smear: a promising tool for diagnosis of visceral leishmaniasis.

Authors:  M Abdus Salam; M Gulam Musawwir Khan; Khondaker Rifat Hasan Bhaskar; Mokibul Hassan Afrad; M Mamun Huda; Dinesh Mondal
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

6.  A novel semiquantitative fluorescence-based multiplex polymerase chain reaction assay for rapid simultaneous detection of bacterial and parasitic pathogens from blood.

Authors:  Angamuthu Selvapandiyan; Katie Stabler; Nasim A Ansari; Stephen Kerby; Jenny Riemenschneider; Poonam Salotra; Robert Duncan; Hira L Nakhasi
Journal:  J Mol Diagn       Date:  2005-05       Impact factor: 5.568

7.  Simplified molecular detection of Leishmania parasites in various clinical samples from patients with leishmaniasis.

Authors:  Claire M Mugasa; Thierry Laurent; Gerard J Schoone; Frank L Basiye; Alfarazdeg A Saad; Sayda El Safi; Piet A Kager; Henk Dfh Schallig
Journal:  Parasit Vectors       Date:  2010-03-02       Impact factor: 3.876

8.  Could kDNA-PCR in Peripheral Blood Replace the Examination of Bone Marrow for the Diagnosis of Visceral Leishmaniasis?

Authors:  Natalia Souza de Godoy; Marcos Luiz Alves Andrino; Regina Maia de Souza; Erika Gakiya; Valdir Sabbaga Amato; José Ângelo Lauletta Lindoso; Lucia Maria Almeida Braz
Journal:  J Parasitol Res       Date:  2016-08-14

Review 9.  Are We Now Well Prepared for Another Major Visceral Leishmaniasis Epidemic in Sudan?

Authors:  Abdallah El Harith; Abdelhafeiz Mahamoud; Yousif Awad; Durria Mansour; Elfadil Mustafa Abass; Atif El Agib; Rubens Riscala Madi; Saul J Semiao-Santos; Hussam Ali Osman
Journal:  Open Forum Infect Dis       Date:  2019-05-15       Impact factor: 3.835

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.